Brain Scientific Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Brain Scientific's earnings have been declining at an average annual rate of -55.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 20.3% per year.
Wichtige Informationen
-55.6%
Wachstumsrate der Gewinne
-23.6%
EPS-Wachstumsrate
Medical Equipment Wachstum der Industrie | 8.9% |
Wachstumsrate der Einnahmen | 20.3% |
Eigenkapitalrendite | -285.9% |
Netto-Marge | -5,753.0% |
Letzte Ertragsaktualisierung | 31 Dec 2022 |
Jüngste Aktualisierungen vergangener Leistungen
Keine Aktualisierungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Brain Scientific Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
31 Dec 22 | 0 | -12 | 9 | 0 |
30 Sep 22 | 0 | -15 | 13 | 0 |
30 Jun 22 | 0 | -12 | 11 | 0 |
31 Mar 22 | 0 | -11 | 10 | 0 |
31 Dec 21 | 0 | -9 | 8 | 0 |
30 Sep 21 | 0 | -3 | 5 | 0 |
30 Jun 21 | 0 | -2 | 4 | 0 |
31 Mar 21 | 0 | -3 | 3 | 0 |
31 Dec 20 | 0 | -3 | 3 | 0 |
30 Sep 20 | 1 | -4 | 1 | 0 |
30 Jun 20 | 1 | -3 | 1 | 0 |
31 Mar 20 | 1 | -2 | 1 | 0 |
31 Dec 19 | 0 | -1 | 1 | 0 |
30 Sep 19 | 0 | -1 | 1 | 0 |
30 Jun 19 | 0 | -1 | 1 | 0 |
31 Mar 19 | 0 | -2 | 1 | 0 |
31 Dec 18 | 0 | -1 | 1 | 0 |
30 Sep 18 | 0 | -1 | 1 | 0 |
30 Jun 18 | 0 | -1 | 1 | 0 |
31 Mar 18 | 0 | -1 | 1 | 0 |
31 Dec 17 | 0 | -1 | 1 | 0 |
Qualität der Erträge: BRSF is currently unprofitable.
Wachsende Gewinnspanne: BRSF is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: BRSF is unprofitable, and losses have increased over the past 5 years at a rate of 55.6% per year.
Beschleunigtes Wachstum: Unable to compare BRSF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: BRSF is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: BRSF has a negative Return on Equity (-285.92%), as it is currently unprofitable.